ORION CORPORATION FINANCIAL STATEMENT RELEASE 2021 10 FEBRUARY 2022 at 12:00 Orion Group Financial Statement Release for 2021 This is a summary or Orion's Financial Statement Release
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Strong performance amid challenges brought on by COVID-19 pandemic
“The COVID-19 pandemic made 2020 an exceptional and demanding year for Orion and for the world. The strong spike in demand for pharmaceuticals seen in March and April brought challenges to Orion’s production and logistics. However, we prevailed due to the strong commitment and hard work of our people. We strived successfully – and will carry on striving – to ensure that pharmaceuticals manufactured and sold by Orion continue to be available to patients. Our current inventory status is good, but we need to keep working to this effect, as the risk of disruptions in global pharmaceutical supply chains remains higher than usual owing to the pandemic. In the current exceptional circumstances, we have prioritised looking after the health and safety of our employees and ensuring production continuity and patient safety in ongoing clinical trials, and we will continue to do so. Amidst the pandemic, we pushed ourselve
Orion Oyj: Orion Group Financial Statement Release for 2020
Orion Group Financial Statement Release for 2020
This is a summary or Orion s Financial Statement Release for 2020. The complete report is attached to this stock exchange release and is available at
https://www.orion.fi/en/Orion-group/investors/financial-reviews-and-presentations/
Net sales totalled EUR 1,078 million (EUR 1,051 million in 2019).
Operating profit was EUR 280 (253) million.
Net sales and operating profit include milestone payments amounting to EUR 42 (51) million.
Profit before taxes was EUR 278 (251) million.
Equity ratio was 67% (77%).
ROCE before taxes was 35% (30%).
ROE after taxes was 29% (26%).
Basic earnings per share were EUR 1.56 (1.43).
Cash flow per share before financial items was EUR 1.85 (1.68).